TY - JOUR
T1 - EULAR recommendations for the use of imaging in the clinical management of peripheral joint osteoarthritis
AU - Sakellariou, Garifallia
AU - Conaghan, Philip G.
AU - Zhang, Weiya
AU - Bijlsma, Johannes W.J.
AU - Boyesen, Pernille
AU - D'Agostino, Maria Antonietta
AU - Doherty, Michael
AU - Fodor, Daniela
AU - Kloppenburg, Margreet
AU - Miese, Falk
AU - Naredo, Esperanza
AU - Porcheret, Mark
AU - Iagnocco, Annamaria
PY - 2017/9/1
Y1 - 2017/9/1
N2 - The increased information provided by modern imaging has led to its more extensive use. Our aim was to develop evidence-based recommendations for the use of imaging in the clinical management of the most common arthropathy, osteoarthritis (OA). A task force (including rheumatologists, radiologists, methodologists, primary care doctors and patients) from nine countries defined 10 questions on the role of imaging in OA to support a systematic literature review (SLR). Joints of interest were the knee, hip, hand and foot; imaging modalities included conventional radiography (CR), MRI, ultrasonography, CT and nuclear medicine. PubMed and EMBASE were searched. The evidence was presented to the task force who subsequently developed the recommendations. The strength of agreement for each recommendation was assessed. 17â 011 references were identified from which 390 studies were included in the SLR. Seven recommendations were produced, covering the lack of need for diagnostic imaging in patients with typical symptoms; the role of imaging in differential diagnosis; the lack of benefit in monitoring when no therapeutic modification is related, though consideration is required when unexpected clinical deterioration occurs; CR as the first-choice imaging modality; consideration of how to correctly acquire images and the role of imaging in guiding local injections. Recommendations for future research were also developed based on gaps in evidence, such as the use of imaging in identifying therapeutic targets, and demonstrating the added value of imaging. These evidence-based recommendations and related research agenda provide the basis for sensible use of imaging in routine clinical assessment of people with OA.
AB - The increased information provided by modern imaging has led to its more extensive use. Our aim was to develop evidence-based recommendations for the use of imaging in the clinical management of the most common arthropathy, osteoarthritis (OA). A task force (including rheumatologists, radiologists, methodologists, primary care doctors and patients) from nine countries defined 10 questions on the role of imaging in OA to support a systematic literature review (SLR). Joints of interest were the knee, hip, hand and foot; imaging modalities included conventional radiography (CR), MRI, ultrasonography, CT and nuclear medicine. PubMed and EMBASE were searched. The evidence was presented to the task force who subsequently developed the recommendations. The strength of agreement for each recommendation was assessed. 17â 011 references were identified from which 390 studies were included in the SLR. Seven recommendations were produced, covering the lack of need for diagnostic imaging in patients with typical symptoms; the role of imaging in differential diagnosis; the lack of benefit in monitoring when no therapeutic modification is related, though consideration is required when unexpected clinical deterioration occurs; CR as the first-choice imaging modality; consideration of how to correctly acquire images and the role of imaging in guiding local injections. Recommendations for future research were also developed based on gaps in evidence, such as the use of imaging in identifying therapeutic targets, and demonstrating the added value of imaging. These evidence-based recommendations and related research agenda provide the basis for sensible use of imaging in routine clinical assessment of people with OA.
KW - Magnetic Resonance Imaging
KW - Osteoarthritis
KW - Ultrasonography
UR - http://www.scopus.com/inward/record.url?scp=85020949925&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85020949925&partnerID=8YFLogxK
U2 - 10.1136/annrheumdis-2016-210815
DO - 10.1136/annrheumdis-2016-210815
M3 - Article
C2 - 28389554
AN - SCOPUS:85020949925
VL - 76
SP - 1484
EP - 1494
JO - Annals of the Rheumatic Diseases
JF - Annals of the Rheumatic Diseases
SN - 0003-4967
IS - 9
ER -